Integer Holdings Corp (ITGR) stock analysis

P/E above its 5-year median

Integer's P/E of 42.5 is above its own 5-year median of 36.2.

P/E above the industry

Integer's P/E of 42.5 is above the Surgical, Medical, and Dental Instruments and Supplies median of 27.7.

EV/EBITDA above its 5-year median

Integer's EV/EBITDA of 19.0 is above its 5-year median of 16.1.

P/B below the industry

Integer's price-to-book of 2.49 is below the Surgical, Medical, and Dental Instruments and Supplies median of 3.22.

Trading above fair value

The share price of $126.68 is above our fair value estimate of $103.47.

Margin of safety under 20%

The price is 22.4% above fair value, so there is no margin of safety.

Revenue growing 10%+ a year

Revenue grew 11.7% a year over the last three fiscal years.

EPS growing 10%+ a year

Diluted EPS grew 13.2% a year over the last three fiscal years.

Earnings growth accelerating

Net income grew 19.3% over the last twelve months, against a 5-year average of 5.9% a year.

Growing slower than the industry

Revenue grew -0.3% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

Guidance lowered

Integer lowered its 2026 Sales outlook on Apr 30, 2026.

Gross margin slipping

Gross margin was 24.6% over the last twelve months, against 26.9% a year earlier.

Return on equity under 15%

Return on equity was 6.0% over the last twelve months and averaged 6.4% over five years; we look for 15% on both.

Return on capital under 10%

Return on invested capital was 5.0%, below the 10% that usually covers the cost of capital.

Return on equity above the industry

Integer's return on equity of 6.0% is above the Surgical, Medical, and Dental Instruments and Supplies median of -31.3%.

Earnings grew over 5 years

Net income grew 5.9% a year on average over the last five fiscal years.

Net margin below its 5-year average

Net margin was 5.7% over the last twelve months, against a 5-year average of 6.3%.

Net margin above the industry

Integer's net margin of 5.7% is above the Surgical, Medical, and Dental Instruments and Supplies median of -14.1%.

High debt

Debt is 70.6% of shareholders' equity, above the 40% we consider low.

Debt rising against equity

Debt to equity rose from 57.5% five years ago to 70.6%.

Debt not well covered by cash flow

Operating cash flow over the last twelve months equals 14.5% of total debt; we look for at least 20%.

Interest not well covered

Operating income covers interest expense 3.9 times; we look for at least 5.

Short-term assets cover short-term debts

Current assets are 3.98 times current liabilities.

Bankruptcy risk in the grey zone

The Altman Z-score is 2.88; above 3 is the safe zone and below 1.8 the distress zone.

No dividend

Integer has not paid a dividend in the last twelve months.

Yield against Treasuries

No dividend.

Yield against the market

No dividend.

Dividend stability

No dividend.

Earnings cover

No dividend.

Cash-flow cover

No dividend.